These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17291221)

  • 1. PPAR alpha agonists improve renal preservation in kidneys subjected to chronic in vitro perfusion: interaction with mannitol.
    Jackson TC; Mi Z; Bastacky SI; McHale T; Melhem MF; Sonalker PA; Tofovic SP; Jackson EK
    Transpl Int; 2007 Mar; 20(3):277-90. PubMed ID: 17291221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of peroxisome proliferator-activated receptor gamma ligand on apoptosis and hepatocyte growth factor induction in renal ischemia-reperfusion injury.
    Doi S; Masaki T; Arakawa T; Takahashi S; Kawai T; Nakashima A; Naito T; Kohno N; Yorioka N
    Transplantation; 2007 Jul; 84(2):207-13. PubMed ID: 17667812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor alpha plays a crucial role in L-carnitine anti-apoptosis effect in renal tubular cells.
    Chen HH; Sue YM; Chen CH; Hsu YH; Hou CC; Cheng CY; Lin SL; Tsai WL; Chen TW; Chen TH
    Nephrol Dial Transplant; 2009 Oct; 24(10):3042-9. PubMed ID: 19491382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists down-regulate alpha2-macroglobulin expression by a PPARalpha-dependent mechanism.
    González MC; Corton JC; Cattley RC; Herrera E; Bocos C
    Biochimie; 2009 Aug; 91(8):1029-35. PubMed ID: 19497347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor alpha activation induces unfavourable changes in fatty acid composition of myocardial phospholipids.
    Baranowski M; Blachnio-Zabielska A; Gorski J
    J Physiol Pharmacol; 2009 Jun; 60(2):13-20. PubMed ID: 19617640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism.
    De Filippis B; Giancristofaro A; Ammazzalorso A; D'Angelo A; Fantacuzzi M; Giampietro L; Maccallini C; Petruzzelli M; Amoroso R
    Eur J Med Chem; 2011 Oct; 46(10):5218-24. PubMed ID: 21889235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of highly potent and selective human peroxisome proliferator-activated receptor alpha agonists.
    Yamazaki Y; Abe K; Toma T; Nishikawa M; Ozawa H; Okuda A; Araki T; Oda S; Inoue K; Shibuya K; Staels B; Fruchart JC
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4689-93. PubMed ID: 17553678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PPAR agonists treatment is effective in a nonalcoholic fatty liver disease animal model by modulating fatty-acid metabolic enzymes.
    Seo YS; Kim JH; Jo NY; Choi KM; Baik SH; Park JJ; Kim JS; Byun KS; Bak YT; Lee CH; Kim A; Yeon JE
    J Gastroenterol Hepatol; 2008 Jan; 23(1):102-9. PubMed ID: 18171348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TXA synthesis with OKY-046 improves liver preservation by prolonged hypothermic machine perfusion in rats.
    Xu H; Lee CY; Clemens MG; Zhang JX
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e212-20. PubMed ID: 17645480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental renal preservation by normothermic resuscitation perfusion with autologous blood.
    Bagul A; Hosgood SA; Kaushik M; Kay MD; Waller HL; Nicholson ML
    Br J Surg; 2008 Jan; 95(1):111-8. PubMed ID: 17696214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy with fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, and simvastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, on experimental traumatic brain injury.
    Chen XR; Besson VC; Beziaud T; Plotkine M; Marchand-Leroux C
    J Pharmacol Exp Ther; 2008 Sep; 326(3):966-74. PubMed ID: 18562561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rosiglitazone treatment attenuates renal tissue inflammation generated by urinary tract obstruction.
    Efrati S; Berman S; Chachashvili A; Cohen N; Siman-Tov Y; Averbukh Z; Weissgarten J
    Nephrology (Carlton); 2009 Apr; 14(2):189-97. PubMed ID: 19143945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis.
    Lin H; Hou CC; Cheng CF; Chiu TH; Hsu YH; Sue YM; Chen TH; Hou HH; Chao YC; Cheng TH; Chen CH
    Mol Pharmacol; 2007 Nov; 72(5):1238-45. PubMed ID: 17671096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
    Assad AR; Delou JM; Fonseca LM; Villela NR; Nascimento JH; Verçosa N; Lopes AG; Capella MA
    Anesth Analg; 2009 Nov; 109(5):1486-92. PubMed ID: 19843786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor-alpha is required for the neurotrophic effect of oleic acid in neurons.
    Bento-Abreu A; Tabernero A; Medina JM
    J Neurochem; 2007 Nov; 103(3):871-81. PubMed ID: 17683485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine acidification has no effect on peroxisome proliferator-activated receptor (PPAR) signaling or epidermal growth factor (EGF) expression in rat urinary bladder urothelium.
    Achanzar WE; Moyer CF; Marthaler LT; Gullo R; Chen SJ; French MH; Watson LM; Rhodes JW; Kozlosky JC; White MR; Foster WR; Burgun JJ; Car BD; Cosma GN; Dominick MA
    Toxicol Appl Pharmacol; 2007 Sep; 223(3):246-56. PubMed ID: 17663016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mannitol and polyethylene glycol on the action of frusemide during renal storage and transplantation.
    Lane NJ; Thorniley MS; Manek S; Fuller BJ; Green CJ
    Transplantation; 1996 Sep; 62(5):575-82. PubMed ID: 8830818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor-alpha contributes to the resolution of inflammation after renal ischemia/reperfusion injury.
    Patel NS; di Paola R; Mazzon E; Britti D; Thiemermann C; Cuzzocrea S
    J Pharmacol Exp Ther; 2009 Feb; 328(2):635-43. PubMed ID: 18997058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.